[{"address1": "1 Great Valley Parkway", "address2": "Suite 24", "city": "Malvern", "state": "PA", "zip": "19355", "country": "United States", "phone": "484 320 2930", "website": "https://www.telabio.com", "industry": "Medical Devices", "industryKey": "medical-devices", "industryDisp": "Medical Devices", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. The company was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.", "fullTimeEmployees": 227, "companyOfficers": [{"maxAge": 1, "name": "Mr. Antony  Koblish", "age": 57, "title": "Co-founder, President, CEO & Director", "yearBorn": 1966, "fiscalYear": 2023, "totalPay": 1031524, "exercisedValue": 0, "unexercisedValue": 102976}, {"maxAge": 1, "name": "Mr. Roberto E. Cuca J.D.", "age": 55, "title": "CFO & COO", "yearBorn": 1968, "fiscalYear": 2023, "totalPay": 674777, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Paul  Talmo", "age": 51, "title": "Chief Technology Officer", "yearBorn": 1972, "fiscalYear": 2023, "totalPay": 595667, "exercisedValue": 0, "unexercisedValue": 23530}, {"maxAge": 1, "name": "Ms. Megan  Smeykal", "age": 47, "title": "VP, Corporate Controller, Chief Accounting Officer & Principal Accounting Officer", "yearBorn": 1976, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. D. Taylor Ocasio", "title": "General Counsel & Corporate Secretary", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jennifer Lou Armstrong", "age": 53, "title": "Senior Vice President of Human Resources", "yearBorn": 1970, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Gregory A. Firestone", "age": 64, "title": "Chief Commercial Officer", "yearBorn": 1959, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Michael  Leonard", "title": "Senior Vice President of Technical Operations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Peter C. Murphy", "age": 50, "title": "Chief Commercial Officer", "yearBorn": 1973, "fiscalYear": 2023, "totalPay": 542339, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Louisa  Smith", "title": "Investor Relations Contact Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 4, "boardRisk": 5, "compensationRisk": 10, "shareHolderRightsRisk": 8, "overallRisk": 9, "governanceEpochDate": 1722470400, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 4.01, "open": 3.2, "dayLow": 2.83, "dayHigh": 3.2, "regularMarketPreviousClose": 4.01, "regularMarketOpen": 3.2, "regularMarketDayLow": 2.83, "regularMarketDayHigh": 3.2, "forwardPE": -2.319672, "volume": 79242, "regularMarketVolume": 79242, "averageVolume": 208833, "averageVolume10days": 145500, "averageDailyVolume10Day": 145500, "bid": 2.67, "ask": 3.55, "bidSize": 200, "askSize": 200, "marketCap": 69774784, "fiftyTwoWeekLow": 2.83, "fiftyTwoWeekHigh": 9.87, "priceToSalesTrailing12Months": 1.0777028, "fiftyDayAverage": 4.8326, "twoHundredDayAverage": 5.606225, "currency": "USD", "enterpriseValue": 113271088, "profitMargins": -0.65038, "floatShares": 13355301, "sharesOutstanding": 24655400, "sharesShort": 2350264, "sharesShortPriorMonth": 955980, "sharesShortPreviousMonthDate": 1719532800, "dateShortInterest": 1722384000, "sharesPercentSharesOut": 0.0953, "heldPercentInsiders": 0.07176, "heldPercentInstitutions": 0.78936, "shortRatio": 9.46, "shortPercentOfFloat": 0.1625, "impliedSharesOutstanding": 24655400, "bookValue": 0.116, "priceToBook": 24.396551, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -42108000, "trailingEps": -1.64, "forwardEps": -1.22, "enterpriseToRevenue": 1.75, "enterpriseToEbitda": -2.485, "52WeekChange": -0.5564159, "SandP52WeekChange": 0.20427191, "exchange": "NGM", "quoteType": "EQUITY", "symbol": "TELA", "underlyingSymbol": "TELA", "shortName": "TELA Bio, Inc.", "longName": "TELA Bio, Inc.", "firstTradeDateEpochUtc": 1573223400, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "abb5ea65-8f6d-31bd-9f7f-997e2cbc5460", "messageBoardId": "finmb_225019977", "gmtOffSetMilliseconds": -14400000, "currentPrice": 2.83, "targetHighPrice": 18.0, "targetLowPrice": 10.0, "targetMeanPrice": 14.2, "targetMedianPrice": 14.0, "recommendationMean": 1.8, "recommendationKey": "buy", "numberOfAnalystOpinions": 5, "totalCash": 26496000, "totalCashPerShare": 1.074, "ebitda": -45588000, "totalDebt": 40817000, "quickRatio": 2.375, "currentRatio": 3.41, "totalRevenue": 64744000, "debtToEquity": 1422.195, "revenuePerShare": 2.635, "returnOnAssets": -0.37547, "returnOnEquity": -1.9642199, "revenueGrowth": 0.11, "grossMargins": 0.69198996, "ebitdaMargins": -0.70413, "operatingMargins": -0.71904, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-08-13"}]